Ekso Bionics Holdings Inc Share Price Deutsche Boerse AG
Equities
US2826441030
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
|
06-25 | Ekso Bionics Announces Research Partnership with Shepherd Center | CI |
06-24 | Lake Street Starts Coverage on Ekso Bionics With Buy Rating, $2.50 Price Target | MT |
Sales 2024 * | 20.52M 18.82M 1.58B | Sales 2025 * | 28.1M 25.78M 2.17B | Capitalization | 24.44M 22.42M 1.88B |
---|---|---|---|---|---|
Net income 2024 * | -9M -8.26M -694M | Net income 2025 * | -4M -3.67M -308M | EV / Sales 2024 * | 1.19 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.87 x |
P/E ratio 2024 * |
-2.61
x | P/E ratio 2025 * |
-5.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.79% |
Latest transcript on Ekso Bionics Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 31/03/21 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 30/04/17 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 56 | 24/12/21 |
Mary Cloyd
BRD | Director/Board Member | 69 | 28/12/20 |
Charles Li
BRD | Director/Board Member | 39 | 10/03/18 |
1st Jan change | Capi. | |
---|---|---|
+4.64% | 208B | |
+8.99% | 182B | |
+29.83% | 155B | |
+35.17% | 115B | |
+2.55% | 66.52B | |
+15.06% | 53.93B | |
-6.47% | 46.26B | |
-2.14% | 38.22B | |
+6.88% | 36.6B |